Vesiflo
Redmond, US · Founded 2012 · Delaware corporation
Vesiflo makes the inFlow device for emptying the bladder and is developing the Guardian Program, a remote monitoring and clinical information system for community-dwelling women with chronic urinary retention. The system automatically transmits urine-output data via an app to the cloud and can alert clinicians or caregivers when output is low.
Founders & leadership
TM
Terrence MooreExecutive Vice President of Marketing and Sales
LV
Loran Van NoyGeneral Manager of Long Term Care Division
JW
John W SullivanChief Financial Officer
KM
Kevin M ConnollyPresident and Chief Executive Officer
SR
Susan RobinsonChief Business Officer
WD
Wayne DeMeesterDirector of Corporate Finance
Reported raises · per SEC filings
Form D private placements$5.6M disclosed across 5 rounds · 2015–2021
▶$87.5KraisedMar 2021 · 3 investors · Other Health CareRule 506(b)
▶$87.5KraisedMar 2021 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Terrance MooreExecutive Officer
- Thomas Van NoyDirector
- Susan RobinsonExecutive Officer
- Kevin ConnollyExecutive Officer, Director
- John SullivanExecutive Officer
- Offering amount
- $600K
- Amount sold
- $87.5K
- Minimum investment
- $12.5K
- Proceeds to insiders
- $1M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$125KraisedMay 2019 · 4 investors · Other Health CareRule 506(b)
▶$125KraisedMay 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Terrance MooreExecutive Officer
- Kevin ConnollyExecutive Officer, Director
- John SullivanExecutive Officer
- Susan RobinsonExecutive Officer
- Thomas Van NoyDirector
- Offering amount
- $1M
- Amount sold
- $125K
- Minimum investment
- $25K
- Proceeds to insiders
- $150K
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedMay 2017 · 55 investors · Other Health CareRule 506(c)
▶$3.3MraisedMay 2017 · 55 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Wayne DeMeesterDirector
- John SullivanExecutive Officer
- Thomas Loran Van NoyExecutive Officer
- Kevin ConnollyExecutive Officer, Director
- Terrance MooreExecutive Officer
- Susan RobinsonExecutive Officer
- Offering amount
- $7M
- Amount sold
- $3.3M
- Minimum investment
- $25K
- Sales commissions
- $300K
- Proceeds to insiders
- $605K
- Placement agents
- Adam Fountain
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06c
▶$50KraisedJan 2016 · 1 investors · ManufacturingRule 506(b)
▶$50KraisedJan 2016 · 1 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Kevin ConnollyExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $50K
- Minimum investment
- $50K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$2MraisedFeb 2015 · 26 investors · ManufacturingRule 506(b)
▶$2MraisedFeb 2015 · 26 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Terrence MooreExecutive Officer
- Loran Van NoyExecutive Officer
- Wayne DeMeesterExecutive Officer
- John W SullivanExecutive Officer
- Kevin M ConnollyExecutive Officer, Director
- Susan RobinsonExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $5K
- Sales commissions
- $27.5K
- Proceeds to insiders
- $300K
- Placement agents
- Broadmark Capital LLC
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Genhealth21 shared keywordsGenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.
Carepatron16 shared keywordsCarepatron provides practice management and clinical workflow software for healthcare clinicians. The platform handles scheduling, patient documentation, billing, and payments in a single application, targeting medical practitioners globally.
Govdelivery15 shared keywordsProvides the Government Experience Cloud (GXC) and Destination Experience Cloud (DXC) platforms, which offer AI-driven, data-based tools and services for public sector digital experiences. Serves governments and destination marketing organizations (DMOs) to help them reach and serve constituents, communities, and destinations.
Companies competing with Vesiflo for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Vesiflo do?
- Vesiflo makes the inFlow device for emptying the bladder and is developing the Guardian Program, a remote monitoring and clinical information system for community-dwelling women with chronic urinary retention. The system automatically transmits urine-output data via an app to the cloud and can alert clinicians or caregivers when output is low.
- How much funding has Vesiflo raised?
- Vesiflo has disclosed $5.6M raised across 5 rounds.
- Where is Vesiflo headquartered?
- Vesiflo is headquartered in Redmond, US.